[1]张蕴鑫 刘建龙* 田轩 蒋鹏 贾伟 程志远 李金勇.Rotarex系统治疗下肢动脉支架内再狭窄的初步经验[J].中国微创外科杂志,2020,01(10):891-895.
 Zhang Yunxin,Liu Jianlong,Tian Xuan,et al.Preliminary Experience of Mechanical Thrombectomy With Rotarex System for Instent Restenosis in Lower Extremity Artery[J].Chinese Journal of Minimally Invasive Surgery,2020,01(10):891-895.
点击复制

Rotarex系统治疗下肢动脉支架内再狭窄的初步经验()
分享到:

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2020年10期
页码:
891-895
栏目:
临床研究
出版日期:
2020-10-25

文章信息/Info

Title:
Preliminary Experience of Mechanical Thrombectomy With Rotarex System for Instent Restenosis in Lower Extremity Artery
作者:
张蕴鑫 刘建龙* 田轩 蒋鹏 贾伟 程志远 李金勇
(北京积水潭医院血管外科,北京100035)
Author(s):
Zhang Yunxin Liu Jianlong Tian Xuan et al.
Department of Vascular Surgery, Beijing Jishuitan Hospital, Beijing 100035, China
关键词:
机械血栓清除术再狭窄血栓
Keywords:
Mechanical thrombectomyRestenosisThrombus
文献标志码:
A
摘要:
目的探讨机械式旋转血栓系统Rotarex治疗髂动脉和股腘动脉处支架内再狭窄的疗效。方法2018年6月~2019年6月我们对20例下肢动脉支架内再狭窄进行机械旋切处理,经造影明确髂动脉或股腘动脉支架内血栓形成,选择Rotarex机械血栓切除系统抽吸血栓。结果介入操作技术成功率为100%,4例存在残余狭窄病变,均行球囊扩张成形,其中2例植入覆膜支架。术前和术后踝肱指数(anklebrachial index,ABI)分别为0.38±0.24、0.91±0.31,差异有显著性(t=6.297,P=0.000)。并发症包括远端栓塞2例,穿刺点血肿2例,无肾功能不全、支架移位及断裂等并发症。20例平均随访13.1月(6~18个月),1例因足趾坏疽合并感染行截趾术。术后6个月一期通畅率为80%(16/20),免于靶血管血运重建率为85%(17/20);术后12个月一期通畅率为75%(15/20),免于靶血管血运重建率为85%(17/20)。结论Rotarex系统治疗下肢动脉支架内再狭窄的短期通畅率令人满意。
Abstract:
ObjectiveTo evaluate the therapeutic effect of Rotarex, a mechanical rotary thrombus system, on instent restenosis in iliac artery and femoral popliteal artery.MethodsA total of 20 patients with instent restenosis in lower extremity artery were treated by mechanical atherectomy from June 2018 to June 2019. The stent thrombosis in iliac artery or femoral popliteal artery was determined by angiography, and the Rotarex mechanical thrombectomy system was utilized for thrombus aspiration.ResultsThe success rate of the interventional procedure was 100%. Four patients had residual stenosis, and all of them underwent balloon dilatation, including 2 cases of coveredstent placement. The anklebrachial index of the 20 patients before and after operation was 0.38±0.24 and 0.91±0.31 (t=6.297, P=0.000), respectively. The complications included distal embolization in 2 cases and puncture site hematoma in 2 cases, respectively. There were no complications such as renal insufficiency, stent displacement or breakage. The 20 patients were followed up for an average of 13.1 months (range, 6-23 months). One patient underwent toe amputation due to gangrene complicated with infection. The primary patency rate at 6 months after surgery was 80% (16/20), and the nontarget vessel revascularization rate was 85% (17/20). The primary patency rate at 12 months after surgery was 75% (15/20), and the nontarget vessel revascularization rate was 85% (17/20).ConclusionThe Rotarex system can be used to treat instent restenosis in lower extremity artery, which gives a satisfactory shortterm patency rate.

参考文献/References:

[1]Dziekiewicz M, Komińska M, Kozaryn R,et al. Traditional vascular imaging methods in peripheral arterial disease-part 1. Chirurgia Polska,2011,13(2):142-148.
[2]刘瑜,宋康兴.介入溶栓结合血管成形术治疗老年下肢动脉闭塞1例分析.中华老年多器官疾病杂志,2013,12(4):316-317.
[3]Tang GL, Chin J, Kibbe M. Advances in diagnostic imaging for peripheral arterial disease. Expert Rev Cardiovasc Ther,2010,8(10):1447-1455.
[4]Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cadiol,2012,59(1):16-23.
[5]Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg,1997,26(9):517-538.
[6Shareghi S, Gopal A, Gul K, et al. Diagnostic accuracy of 64 multidetector computed tomographic angiography in peripheral vascular disease. Catheter Cardiovasc Interv,2010,75(1):23-31.
[7]Wissgott C, Kamusella P, Andresen R. Recanalization of acute and subacute venous and synthetic bypassgraft occlusions with a mechanical rotational catheter. Cardiovasc Intervent Radiol,2013,36(4):936.
[8]Iida O, Nanto S, Uematsu M, et al. Influence of stent fracture on the longterm patency in the femoropopliteal artery: experience of 4 years. JACC Cardiovasc Interv,2009,2(7):665-671.
[9]Tepe G, Schmitmeier S, Speck U, et al. Advances on drugcoated balloons. J Cardiovasc Surg(Torino),2010,51(1):125-143.
[10]Freitas B, Steiner S, Bausback Y, et al. Rotarex mechanical debulking in acute and subacute arterial lesions. Angiology,2017,68(3):233-241.
[11]Kronlage M, Printz I, Vogel B, et al. A comparative study on endovascular treatment of (sub)acute critical limb ischemia: mechanical thrombectomy vs thrombolysis. Drug Des Devel Ther,2017,11(4):1233-1241.
[12]Liu J, Li T, Huang W. Percutaneous mechanical thrombectomy using Rotarex catheter in peripheral artery occlusion diseasesExperience from a single center. Vascular,2019,27(2):199-203.
[13]Caetano AP, Gomes FV, Bilhim T, et al. Percutaneous mechanical thrombectomy with rotarex using the retrograde posterior tibial artery approach for recanalization of superficial femoral artery instent occlusion. J Vasc Interv Radiol,2019,30(10):1691-1693.
[14]Duc SR, ScPfyffer M, Jenelten R, et al. Recanalization of acute and subacute femoropopliteal artery occlusions with the Rotarex catheter: one year followup, single center experience. Cardiovasc Intervent Rariol,2005,28(8):603-610.
[15]乔延松,吕引娣,孙超,等.AngioJet血栓清除联合置管溶栓治疗下肢急性缺血.中国微创外科杂志,2019,19(10):882-886.
[16]Heller S, Lubanda JC, Varejka P, et al. Percutaneous mechanical thrombectomy using Rotarex S device in acute limb ischemia in infrainguinal occlusions. Biomed Res Int,2017,2017:2362769.

备注/Memo

备注/Memo:
*通讯作者,Email:ljl_hy88@sina.com
更新日期/Last Update: 2021-01-13